Lateral Flow Assays Market is Expected to Reach $16.8 billion | MarketsandMarkets™

Advertisement

Chicago, March 15, 2024 (GLOBE NEWSWIRE) — Lateral Flow Assays market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of 7.6% from 2023 to 2029 according to a latest report published by MarketsandMarkets™. In this report, the lateral flow assays market is segmented on the basis of product type, application type, technique type, sample type, end user, and region.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133

Lateral Flow Assays Market Scope:

Advertisement

Report Coverage Details
Market Revenue in 2023 $10.8 billion
Estimated Value by 2029 $16.8 billion
Growth Rate Poised to grow at a CAGR of 7.6%
Market Size Available for 2021–2029
Forecast Period 2023–2029
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Product type, Application type, Technique type, Sample type, End User and Region
Geographies Covered
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East and Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Low adoption of phacoemulsification devices and premium IOLs in emerging regions
Key Market Driver Increase in eye disorders

Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. In 2022, The lateral flow readers is accounted for the second largest share of the global lateral flow assays market. The huge share  of this segment is as the readers allow to do the quantitative analysis of lateral flow strips in various tests such as sandwich, competitive, and reverse-competitive test formats. These readers enable to measure the intensity of the test line to determine the number of analytes in the sample and provide a fully quantitative assay result.

Based on the type of applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The veterinary diagnostics segment accounted for the second largest share of the lateral flow assays market in 2022. The large share of this segment can be attributed to as the application of synthetic as well as recombinant peptide antigens accompanied with monoclonal antibodies has given rise to advancements in sensitivity, usability and specificity. The availability in veterinary diagnostics to conduct such tests with affordability tends to be the factor which boosts the market growth.

Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The competitive assay technique holds the second largest share in the lateral flow assays market in 2022. The growth of technique is attributed due to the increase in the demand for technologies which are capable in extracting huge amount of bioinformation from limited volume of samples which are used for better diagnosis as well as these are being used  to measure the binding of a labelled ligand which are used to target the protein.

Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the second largest market share of in 2022. The use of urine samples is commonly used in lateral flow diagnostic testing for pregnancy testing and drugs-of-abuse testing. The urine samples are also being used in detecting certain infectious disease testing, such as TB and Legionella.

Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The Diagnostic Laboratories segment accounted for the third largest market share in 2022. The high growth of this segment is attributed to various factors such as laboratories offer various types of diagnostic options and provides the faster results for tests that are in the latest research stage. Such tests are highly complex and unique. Laboratory testing is preferred over professional settings for urine and blood sample testing due to the better-quality standards offered.

Based on the regions, the lateral flow assays market is segmented into North America, Europe, Asia Pacific, Latin America, GCC countries and the Middle East & Africa. In 2022, Europe is the second largest region in the lateral flow assays market in 2022. This of large segment of this region is is attributed to the growth in the demand for decentralized diagnostic tests, the increasing requirement for safer and high-throughput diagnostic procedures (especially for the geriatric population) and increasing funding & investments.

Buy a Lateral Flow Assays Industry Report (399 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=167205133

Lateral Flow Assays market major players covered in the report, such as:

  • Bausch Health Companies
  • Inc. (Canada)
  • Alcon (Switzerland)
  • Carl Zeiss Meditec AG (Germany)
  • Johnson & Johnson (US)
  • Hoya Corporation (Japan)
  • The Cooper Companies, Inc.(US)
  • EssilorLuxottica (France)
  • Canon Inc. (Japan)
  • Glaukos Corporation (US)
  • Nidek Co., Ltd. (Japan)
  • Topcon Corporation (Japan)
  • Ziemer Ophthalmic Systems (Switzerland)
  • Staar Surgical (US)
  • Haag-Streit (Switzerland)
  • Quantel Medical (US)
  • Coburn Technologies, Inc. (US)
  • FCI Ophthalmics (US)
  • Matronix India Corporation (India)
  • HEINE Optotechnik (Germany)
  • Visionix (France)
  • Neo Vision (Korea)
  • Clear Lab (Singapore)
  • BVI (US)
  • DORC (Netherlands)
  • CORZA Medical (US)
  • Appasamy Associates (India)
  • Ophtec BV (Netherlands)
  • Lumenis (Israel)
  • Intuvision Labs (India)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=167205133

The research report categorizes lateral flow assays market into the following segments and sub-segments:

By Type

  • Kits & Reagents
  • Lateral Flow Readers

By Application

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environmental Testing
  • Drug Development & Quality Testing

By Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Sample Type

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Other Samples

By End User

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Pharmaceuticals & Biotechnology Companies
  • Other End USer

By Country

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East and Africa

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133

Key Market Stakeholders:

  • Ophthalmology Device Manufacturers
  • Ophthalmology Surgical Devices Manufacturers
  • Ophthalmology Diagnostic & Monitoring Devices Manufacturers
  • Vision Care Products Manufacturers
  • Suppliers and Distributors of Ophthalmology Devices

Report Objectives:

  • To define, describe, and forecast the global lateral flow assays market based on the product, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall lateral flow assays market
  • To analyze opportunities in the global lateral flow assays market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global lateral flow assays market with respect to five regions—North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
  • To profile key players in the lateral flow assays market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product launches and approvals, agreements, partnerships, collaborations, acquisitions, joint ventures, spin-offs, expansions, and R&D activities of leading players in the global lateral flow assays market
  • To benchmark players in the market using the “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy within the lateral flow assays market

Related Reports:

Veterinary Diagnostic Market

Immunoassay Market

Companion Animal Diagnostics Market

Veterinary Infectious Disease Diagnostics Market

Over The Counter/OTC Test Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/lateral-flow-assay-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/lateral-flow-assay.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.